ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 183

Collaboration Between Rheumatology Clinic and Specialty Pharmacy to Positively Impact Patient Experience and Hospital Stewardship

Alaina Linafelter1, Julia Harris 2, Rob Herr 1, Stephanie Quinn 1 and Ashley Cooper 3, 1Children's Mercy Kansas City, Kansas City, Missouri, 2Children's Mercy Kansas City, Overland Park, 3Children's Mercy Kansas City, Kansas City

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: Biologics, Multidisciplinary, Specialty, Specialty Pharmacy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Saturday, May 2, 2020

Title: Poster Session 3

Session Type: ACR Abstract Session

Session Time: 4:15PM-5:15PM

Background/Purpose: Biologic medications are commonly utilized to treat pediatric rheumatic diseases.  Being high-cost, most third-party payors require dispensing through a specialty pharmacy.  Common challenges with this system include delayed or missed medication shipment, adult-trained pharmacists and difficulty communicating with representatives. In March 2015, our health system opened their own specialty pharmacy, available to a certain subset of patients based on insurance coverage. The Rheumatology Clinic aimed to improve medication delivery timeliness, patient satisfaction, and hospital stewardship via collaboration with our institution’s Specialty Pharmacy (SP) when appropriate and applicable.

Methods: Throughout the last year, the rheumatology team increased utilization of the SP through a multidisciplinary approach.  The office manager identified potential patients and communicated with the SP pharmacist to gauge eligibility.  Providers were notified of eligible patients and discussed the SP in clinic with families when appropriate. Providers and/or nursing staff communicated with the SP pharmacist to verify eligibility and expedite processing.  The SP pharmacist initiated the prior authorization process and contacted family to enroll the patient.  Surveys were distributed by the SP to analyze patient and family satisfaction and collect feedback.

Results: From August 2018 to August 2019, the number of rheumatology patients utilizing our health system SP increased from 2 to 67.  On average, 13.6 days elapsed between the day the order was placed and when the medication was dispensed, compared to a national average of 3-6 weeks.1 When 59 families were asked if their medications were delivered on time, 98.3% answered “yes, definitely”.  All families who had previously attempted to call the SP answered positively when asked if it was easy to contact someone if they had questions, with 96.4% saying “yes, definitely”. In rating their specialty pharmacy experience, (0-10), 96.6% selected 10, and 3.4% selected 9.  $1,176,557 of new net revenue was generated by rheumatology patients utilizing the SP in fiscal year 2019.

Conclusion: The number of patients benefited by the superior service of our health system SP has risen steadily over the last year, leading to high patient satisfaction and financial benefits for the hospital. The revenue generated from this initiative helped secure approval for a new clinical pharmacist position in rheumatology, further benefitting our patients. The rheumatology team plans to continue this initiative by actively working as a multidisciplinary team to identify eligible patients.  Future goals include having our SP recognized by other third-party payors, enabling more families to qualify for this service and receive the timely, patient-focused care.

  1. 2018-19 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Adam J. Fein, Ph.D. Drug Channels Institute – October 2018.


Disclosure: A. Linafelter, None; J. Harris, None; R. Herr, None; S. Quinn, None; A. Cooper, None.

To cite this abstract in AMA style:

Linafelter A, Harris J, Herr R, Quinn S, Cooper A. Collaboration Between Rheumatology Clinic and Specialty Pharmacy to Positively Impact Patient Experience and Hospital Stewardship [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/collaboration-between-rheumatology-clinic-and-specialty-pharmacy-to-positively-impact-patient-experience-and-hospital-stewardship/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/collaboration-between-rheumatology-clinic-and-specialty-pharmacy-to-positively-impact-patient-experience-and-hospital-stewardship/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology